Product Description
| Name |
Sonwu Supply OEM Capsules Raw Powder Lapatinib Ditosylate |
| CAS NO. |
388082-78-8 |
| Molecular Formula |
C12h17cln2s |
| MW |
925.46 |
| Purity |
99% |
| Appearanc |
White Powder |
| Certificate |
ISO, SGS, GMP, HACCP |
| MOQ |
10 g |
| Shelf life |
2 Years |
Lapatinib produced by glaxosmithkline. Epidermal growth factor receptor tyrosine kinase inhibitor, an oral administration of small molecules. Mainly used for joint card of capecitabine in the treatment of erbB-2 overexpression, who previously received including anthracyclines and paclitaxel and trastuzumab (Herceptin) in the treatment of advanced or metastatic breast cancer. When taking the need to pay attention to its adverse reactions.
In the experiment of Chinese hamster, no carcinogenic effect was found, and no genetic toxicity was found. There was no effect on mating ability and fertility of rats under high dose. There are 1 cases reported in pregnant women in March before taking lapatinib, full-term pregnancy after the birth of healthy children .
Lapatinib in Indonesia and capecitabine combination in the treatment of breast cancer, the effect is better, and of anthracene ring antibiotics, taxanes and trastuzumab resistant patients effective, mild side effects, for advanced or metastatic breast cancer patients and a drug treatment.
Detailed Photos
Certifications
Functions
Lapatinib is a targeted therapy of breast cancer drug, is a tyrosine kinase inhibitor, can effectively inhibit the human epidermal growth factor receptor -1 (ErbB1) and human epidermal growth factor receptor (ErbB2) tyrosine kinase activity of -2. It is unique in that it can play a role in a variety of ways, so that breast cancer cells can not receive the signal needed for growth. The mechanism of action is to inhibit the intracellular EGFR (ErbB-1) and HER2 (ErbB-2) ATP sites to prevent phosphorylation and activation of tumor cells, and to block the down-regulation of signaling by EGFR (ErbB-1) and HER2 (ErbB-1) homogeneous and heterogeneous two aggregates.
Molecular targeted therapy for breast cancer is the treatment of oncogenes and related expression products related
to the occurrence and development of breast cancer. Molecular targeted drugs control cell gene expression by
blocking the signal transduction of tumor cells or related cells, thereby inhibiting or killing tumor cells.
You may interested in:
| Other Hot-Selling Similar Product |
| Gefitinib |
Lapatinib |
AZD9291 |
Niraparib |
| Dasatinib |
Imatinib |
Ibrutinib |
Niraparib tosylate monohydrate |
| LOXO 195 |
LOXO 101 |
Fluconazole |
Cabozantinib Malate |
| baricitinib |
ketoconazole |
Imatinib mesylate |
Erlotinib Hydrochloride |
OEM Service
HARD CAPSULE
Type: 0# 1# 2# 3#
Color: More than 30 colors are available.
Capsules have a hard shell, and either contain powders or dry ingredients. Suitable for all kinds of plant extract powder.
TABLET
Type: 250mg 500mg 1000mg 2000mg
Professional Mould, Provide you tablets of various shapes.
Tablets are a harder dosage form compared to softgels and capsules. Suitable for all kinds of plant extract powder.
SOFTGEL
Model: 500mg 1000mg 2000mg...
Softgels have a gelatin shell, surrounding a gel or liquid interior.Suitable for all kinds of animal and plant essential oils.
BOTTLE
Type: PET, PE(HDPE),....
Volume:60cc,120cc, 150cc, 200cc, 250cc...
Customized size,color and label design are available.
SMALL BAG PACKAGE
Type: 10g, 50g, 100g, 500g, 1000g, 2000g...
Small bag is also a good choice for a small amount of contents packaged.Customized size,color and label design are available.
Packaging & Shipping
Feedbacks
FAQ
1. Customs clearance
1) By Express:
Normally there is no special need for the recipient to clear the customs. If the customs has an objection,our rich experienced and professional group will help you clear the customs.
2) By Air and by Sea:
Our company will cooperate with the recipient to provide relevant file and information in the customs clearance procedure.
2. Payment
T/T,Western Union,MoneyGram,Trade Assurance Order,L/C etc.
Audited Supplier 
){kind=link}
){kind=link}